Hipertansiyon İçin Birinci Basamak Kullanımına Yönelik Kanıta Dayalı Bir Rehber Çalışması

Öz

Özet: 

Hipertansiyon sistolik kan basıncının 140 mm Hg, ve/veya diyastolik kan basıncının 90 mm Hg’nın üzerinde olmasıyla giden hastalıktır. Dünya’da en önde gelen ölüm nedenidir. Yüksek prevelansı nedeniyle birinci basamakta en sık karşılaşılan hastalıklardandır.

Anahtar Kelimeler

• Hipertansiyon,birinci basamak,rehber

AN EVIDENCE BASED GUIDELINE FOR HYPERTENSION IN PRIMARY CARE

Öz

Hypertension is a disorder defined as systolic blood pressure greater than 140 mm Hg and/or diastolic blood pressure greater than 90 mm Hg. It is the leading death cause

worldwide. Hypertension is one of the most commonly encountered diseases in primary care, according to the high

prevalence rates. 

Anahtar Kelimeler

• Hypertension,primary care,guideline

Kaynakça

1. 1. Wolf-Maier K, Cooper RS, Banegas JR, et al.Hypertension prevalence and blood pressurelevels in 6 European countries, Canada, and the United States. JAMA 2003;289(18):2363e9.
2. 2. İ.Satman ve TURDEP çalışma grubu, 2011.
3. 3. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected majör risk factors and global and regional burden of disease. Lancet 2002;360:1347–1360. RV.
4. 4. World Health Report. Reducing risks, promoting healthy life. Geneva (Switzerland): World Health Organization; 2002. Available at: http://www.who.int/whr/2002/en/ whr02_en.pdf.
5. 5. Ogedegbe G, Pickering TG. Chapter 68. Epidemiology of Hypertension. In: Fuster V, Walsh RA, Harrington RA, eds. Hurst›s The Heart. 13th ed. New York: McGrawHill; 2011. http://www.accessmedicine.com/content. aspx?aID=7823628. Accessed November 18, 2012
6. 6. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.
7. 7. 7-Mancia G et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
8. 8. National Institute for Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults (update). (Clinical guideline 127.) 2011. http:// guidance.nice.org.uk/CG127.

9. 9. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011;342:d3621.
10. 10. Arteriyel Hipertansiyon Tedavisi 2007 Kılavuzu, Türk Kardiyol Dern Arş Suppl 3, 2007
11. 11. The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension:Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy Canadian Journal of Cardiology 28 (2012) 270–287
12. 12. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) European Heart Journal (2012) 33, 1635–1701
13. 13. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665
14. 14. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook SW, Williams B, Ford GA. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomised controlled trials. J Hypertens 2006;24:215– 233. MA.
15. 15. Mensah GA, Bakris G. Treatment and control of high blood pressure in adults. Cardiol Clin. 2010 Nov;28(4):609-22.
16. 16. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.